Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2024

Genmab — Marts 2024

Planlagt Fastgjort Låst Flyttet Genmab
830 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #90

    Hold the Press!!! Is that an insider purchase in the open market?

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #91

      Det er i hvert fald et bestyrelsesmedlem der har købt ADS´ere

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #92

        Servicemeddelelse. Marketwire har tekniske udfordringer her til morgen og leverer derfor ikke nyheder til vort feed.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #93

          An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy / Tisotumab - https://aacrjournals.org/mct/article-abstract/23/2/187/733943/An-Antibody-Drug-Conjugate-Directed-to-Tissue?redirectedFrom=fulltext

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #94

            the GEN1046 Endometrial trial ads a few more trial centers , Cohort A closed already, could this be a sign of quick recruitment? https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=7&B=8&C=Side-by-Side#StudyPageTop

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #95

              separate new Epcoritamab trial by the Australasian Leukaemia and Lymphoma Group https://clinicaltrials.gov/study/NCT06287398

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #96

                Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders https://news.cision.com/h--lundbeck-a-s/r/lundbeck-presents-encouraging-results-from-the-lu-af82422-trial-for-multiple-system-atrophy-at-the-i,c3940069

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #97

                  Thanks E L . 🙂

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #98

                    😉

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #99

                      not sure i ever heard of Baader Bank, but it seems they have a buy - Genmab $GMAB 1,954DKK
                      Baader. Buy. 3,239 ▶️ 3,446DKK https://twitter.com/Quality_stocksA/status/1764913792394129790

                      1 Reply Last reply
                      0
                      • B Offline
                        B Offline
                        bikube
                        wrote on sidst redigeret af
                        #100

                        Der er noget galt i den meddelelse om insiderkøb. Jeg får det til, at hun har givet $39,70 - kursen på Ads er 28,51.

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #101

                          27,7881 er kursen per ADS ikke købsprisen (277881) for de 7000 stk men 7000stk x 27,7881 = 194.516,7 USD totalt 🙂

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Pensionisten
                            wrote on sidst redigeret af
                            #102

                            I meddelelsen fra Genmab angives kurs 27,881, og handelsdato 28. feb.

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #103

                              Okay - så giver det mening.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #104

                                Lundbeck gør klar til fase 3-studie af MSA-middel efter opmuntrende data
                                Lundbeck bekræfter sine planer om at gå i fase 3 med en kandidat mod multipel system atrofi. https://medwatch.dk/Medicinal___Biotek/article16905404.ece

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #105

                                  Der kun de hardcore support-abonnenter tilbage på chatten. Har alle andre solgt ud 😉

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gdn55
                                    wrote on sidst redigeret af
                                    #106

                                    Hvis du ikke har bemærket det, steg Genmab en lille smule idag, derfor ikke så mange indlæg. Det er mit bedste bud.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #107

                                      😉

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #108

                                        Det kunne have noget at gøre med de hygiejneprogrammer, der kører overfor skribenter, der frembringer kritiske indlæg

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #109

                                          Det er jo ikke alt, der er velkomment her

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper